CARDIOVASCULAR RISK, BIOLOGICS AND ANTI-CYCLIC CITRULLINATED PEPTIDE POSITIVITY IN RHEUMATOID ARTHRITIS

被引：1

作者：

Jauregui, E. A. ^{[1
]}

Agudelo, C. A. ^{[1
]}

Aldana, C. ^{[1
]}

Munoz, Y. A. ^{[1
]}

机构：

[1] Riesgo Fractura SA CAYRE, Rheumatol, Bogota, Colombia

来源：

关键词：

D O I：

10.1136/annrheumdis-2017-eular.6465

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0313

引用

页码：1158 / 1158

页数：1

共 3 条

[1] AHA/ACC/HHS Strategies to Enhance Application of Clinical Practice Guidelines in Patients With Cardiovascular Disease and Comorbid Conditions From the American Heart Association, American College of Cardiology, and US Department of Health and Human Services
Arnett, Donna K.
Goodman, Richard A.
Halperin, Jonathan L.
Anderson, Jeffrey L.
Parekh, Anand K.
Zoghbi, William A.
[J]. CIRCULATION, 2014, 130 (18) : 1662 - +
[2] Goff Jr DC, 2013, ACC/AHA Cardiovascular Risk Guideline Page 1 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology
[3] EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Peters, M. J. L.
Symmons, D. P. M.
McCarey, D.
Dijkmans, B. A. C.
Nicola, P.
Kvien, T. K.
McInnes, I. B.
Haentzschel, H.
Gonzalez-Gay, M. A.
Provan, S.
Semb, A.
Sidiropoulos, P.
Kitas, G.
Smulders, Y. M.
Soubrier, M.
Szekanecz, Z.
Sattar, N.
Nurmohamed, M. T.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) : 325 - 331